Americas was Pacific Biosciences Of California’s largest region in fiscal 2025, bringing in $72.80M of $160.01M (45%).
| Geography | FY 2010 | FY 2012 | FY 2015 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas | $69.56M | $105.41M | $78.71M | $72.80M | ||||||||
| North America | — | — | — | — | ||||||||
| Asia-Pacific | $36.15M | $54.45M | $40.71M | $43.16M | ||||||||
| Asia Pacific | — | — | — | — | ||||||||
| Asia Pacific (Including The Middle East) | — | — | — | — | ||||||||
| Europe, Middle East, & Africa | $22.60M | $40.66M | $34.59M | $44.05M | ||||||||
| Europe, Middle East & Africa | — | — | — | — | ||||||||
| Europe (Including The Middle East & Africa) | — | — | — | — | ||||||||
| Europe | — | — | — | — | ||||||||
| Asia | — | — | — | — | ||||||||
| United States | — | — | — | — | ||||||||
| Revenues | — | — | — | — | ||||||||
| Total | $128.30M | $200.52M | $154.01M | $160.01M |
Pacific Biosciences Of California brought in $160.01M from its three regions in fiscal 2025, the year ended December 31, 2025. That was up 3.9% from $154.01M in fiscal 2024. Americas was the largest at $72.80M (45.5%), ahead of Europe, Middle East, & Africa at $44.05M (27.5%) and Asia-Pacific at $43.16M (27.0%).
Compared with fiscal 2024, Europe, Middle East, & Africa grew fastest, up 27.3% to $44.05M, while Americas fell the most, down 7.5% to $72.80M. From fiscal 2022 to 2025, combined revenue from these regions grew from $128.30M to $160.01M, a compound annual growth rate of 7.6%. Americas' share of the total fell from 54.2% to 45.5%.
Consumables Revenue was Pacific Biosciences Of California’s largest product and service line in fiscal 2025, bringing in $81.94M of $160.01M (51%).
| Product and Service | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Instrument Revenue | $48.72M | $120.45M | $65.78M | $53.82M | ||||||
| Instrument | — | — | — | — | ||||||
| Consumables Revenue | — | $63.42M | $70.37M | $81.94M | ||||||
| Consumable Revenue | $59.98M | — | — | — | ||||||
| Consumable | — | — | — | — | ||||||
| Service & Other Revenue | $19.61M | $16.65M | $17.87M | $24.25M | ||||||
| Service & Other | — | — | — | — | ||||||
| Total | $128.30M | $200.52M | $154.01M | $160.01M |
Pacific Biosciences Of California brought in $160.01M from its three product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 3.9% from $154.01M in fiscal 2024. Consumables Revenue was the largest at $81.94M (51.2%), ahead of Instrument Revenue at $53.82M (33.6%) and Service & Other Revenue at $24.25M (15.2%).
Compared with fiscal 2024, Service & Other Revenue grew fastest, up 35.7% to $24.25M, while Instrument Revenue fell the most, down 18.2% to $53.82M.
Pacific Biosciences Of California began breaking out Consumables Revenue in fiscal 2023, when it brought in $63.42M. Pacific Biosciences Of California stopped reporting Consumable Revenue as a separate line after fiscal 2022, when it brought in $59.98M.
Pacific Biosciences Of California (PACB) reports its revenue by geography and by product and service. In fiscal 2025, Americas was its largest region, bringing in $72.80M (45.5% of the total), followed by Europe, Middle East, & Africa at $44.05M (27.5%).
Americas was Pacific Biosciences Of California's largest region in fiscal 2025, bringing in $72.80M, or 45.5% of the $160.01M total across its three regions.
Consumables Revenue was Pacific Biosciences Of California's largest product and service line in fiscal 2025, bringing in $81.94M, or 51.2% of the $160.01M total across its three product and service lines.
Among Pacific Biosciences Of California's regions that make up at least 2% of revenue, Europe, Middle East, & Africa grew fastest in fiscal 2025, up 27.3% from $34.59M to $44.05M.
Every figure comes from Pacific Biosciences Of California's annual financial filings, as reported. Each line keeps the name Pacific Biosciences Of California gives it, and years follow its fiscal calendar.
Pacific Biosciences Of California's revenue by geography goes back to fiscal 2010, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.